Pfizer is to reduce manufacturing staffing by around 6,000 – around 18% of its total production workforce – and close …
This builds further upon Chiltern’s well established operation in India. Chiltern is also in the process of forming a company …
UCB’s chief executive Roch Doliveux has joined the governing board of the Innovative Medicines Initiative. The IMI is a public-private …
The Spanish government will cut the prices of patented prescription drugs from 1 August in a bid to save 1.3 …
A new business aimed at helping entrepreneurs and run by two former directors of Synovate Healthcare has launched in London. …

Ferring UK has appointed Steve Howson as its new general manager. He will have responsibility for operations in the UK …

Professor Dame Sally Davies will take on the role of interim chief medical officer when Sir Liam Donaldson retires as …
European regulators are readying themselves to deal with the region’s first marketing authorisation application for a stem cell product. The …
Pfizer is teaming up with academia in a five-year bid to discover new uses for existing compounds. The pharma manufacturer …
Bayer Schering Pharma has expanded its global research network, opening a new Innovation Center in San Francisco. The US centre …
Merck & Co’s heart disorder drug Brinavess has proved superior to rival amiodarone in reducing rates of atrial fibrillation in …
Health Secretary Andrew Lansley has warned the NHS may face deeper cuts than expected. Lansley, who was appointed Health Secretary …
The US Food and Drug Administration has taken the advice of its advisors and given its backing to resume the …
New trials of a daily polypill – combining aspirin, a statin and two blood pressure lowering medicines – are underway …
Takeda is planning to cut its workforce by 10% through a series of cuts that will predominantly be made to …

After four months and several failed bids Astellas Pharma has signed a definitive merger agreement with US biotech firm OSI …
by Kathryn Bennett, Managing Director – TVF Communications
Some consider it just another channel to market, but the reality is more complicated.by Mark Millar, PraeMedica

The UK’s Code of Practice regulator will produce guidance for pharma on digital marketing, but is reluctant to make formal …
by Matthew Baker, Deputy Managing Director – LEC